March 03, 2026

Ivermectin vs Permethrin for Scabies

Investigators evaluate household-level cure rates in dermoscopy-confirmed cases at day 28.

Conexiant

March 02, 2026

Gene Test Guides Eczema Care

Skin scraping assay may help labs support targeted systemic treatment in atopic dermatitis

The Pathologist

February 27, 2026

Unexpected Diagnosis in Ring Finger Mass

Histopathology reveals digital actinomycosis in a young patient.

Conexiant

February 19, 2026

Afro-Textured Hair: Clinical Framework for Care

Investigators examine clinician communication, updated hair classification, and culturally informed care in Afro-textured hair.

Conexiant

February 18, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Conexiant

February 12, 2026

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

Conexiant

February 12, 2026

Connecting the Diagnostic Dots in HIES

Clinical case report highlights how classic features of STAT3 hyper-IgE syndrome can be routinely missed in pediatric practice

Conexiant

February 10, 2026

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Conexiant

February 10, 2026

Novel LIFR Variant Identified in Stuve-Wiedemann Syndrome

Case report highlights the role of early genetic confirmation in severe skeletal dysplasia

Conexiant

February 09, 2026

Dupilumab and Lymphoma Risk in AD?

Dupilumab is safe from a lymphoma-risk perspective in atopic dermatitis and other type 2 inflammatory diseases, based on real-world data.

Conexiant